Core Technology

LepiDyne has a liquid biopsy–suitable biomarker discovery pipeline, a detection method, and optimized reagents.

Biomarker Discovery Technology
We used multiomics big data and machine learning to establish a DNA methylation biomarker discovery pipeline. We are continuously searching for new cancer biomarkers.
LepiMA: A cancer-specific methylation marker discovery platform
Liquid Epiallele Melting Analyzer
The platform complements the previous methylation detection method and is optimized for liquid biopsy. The melting temperature differences due to methylation determine the ratio between the methylated and non-methylated product and reflect the tumor heterogeneity.